SGP financials

SpyGlass Pharma (SGP) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

SGP income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025––-$41.45M-$39.87M-17.98
2024––-$27.06M-$29.16M-16.31